Expres2ion CEO after first full financial year: “We are in unique position to expand”

Danish biotech company Expres2ion Biotechnologies has reported the results of the first full financial year after the IPO in July 2016. Despite the SEK 10 million deficit, the CEO is optimistic.

Photo: Expres2ion

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles